Results 51 to 60 of about 268,538 (298)
The angiotensin converting enzyme inhibitors – alternative clinical applications
Journal of Medical Science, 2014 Angiotensin converting enzyme inhibitors have emerged as a useful strategy in the management of hypertension and other cardiovascular system-related diseases.
Beata Stanisz +2 more
doaj +1 more source
Hematology, 2023 Objective: Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery of a mutation in the Janus kinase 2 (JAK2V617F)
Angela Bozza +5 more
doaj +1 more source
Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study [PDF]
, 2017 Background: Angiotensin converting enzyme inhibitors (ACEIs) are recommended as first-line therapy in patients with heart failure with reduced ejection fraction (HFrEF). The comparative effectiveness of different ACEIs is not known. Methods and results:
Agewall, Stefan +14 more
core +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Evidence‐based medication adherence rates after a myocardial infarction are low. We hypothesized that 90‐day prescriptions are underused and may lead to higher evidence‐based medication adherence compared with 30‐day fills. Methods and Results
Jennifer A. Rymer +5 more
doaj +1 more source
Angiotensin-Converting Enzyme Inhibitors Induce Cough.
Turkish Thoracic Journal, 2019 Angiotensin-converting enzyme inhibitors (ACE-I) are widely used in diseases, such as hypertension, congestive heart failure, and myocardial infarction. Although these drugs are well tolerated, one out of five patients discontinues ACE-I due to drug side
I. Yilmaz
semanticscholar +1 more source
Benzophenone Semicarbazones as Potential alpha-glucosidase and Prolyl Endopeptidase Inhibitor: In-vitro free radical scavenging, enzyme inhibition, mechanistic, and molecular docking studies [PDF]
arXiv, 2023 $\alpha$-glucosidase and prolylendopeptidase has altered expression and activity patterns in neurological disease, type 2diabetes respectively and several cancers. Here we screened a series 1-29 benzophenone semicarbazone derivatives for in vitro free radical scavenging, alpha-glucosidase and prolylendopeptidase inhibition activities. Seven derivatives
arxiv
Oftalʹmologiâ, 2020 Diabetic retinopathy (DR) is becoming more and more widespread disease. Investigation of local changes of metabolic pathways in the eye improves our knowledge about diabetic retinopathy pathogenesis and provide perspective for the development of new ...
V. V. Neroev +6 more
doaj +1 more source
Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia
Proceedings, 2018 Angiotensin-converting enzyme (ACE) inhibitors and statins may potentially benefit patients with viral infections and pneumonia. Our study aimed to evaluate the impact of ACE inhibitors and statins on the rates of intubation and death in viral pneumonia.
Christopher Henry +5 more
semanticscholar +1 more source
Clinics, 2012 OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients.
Taner Basturk +6 more
doaj +1 more source
JAMA Network Open, 2019 Key Points Question Are angiotensin receptor blockers associated with a higher risk of suicide than angiotensin-converting enzyme inhibitors? Findings In this case-control study of 964 older adults who died by suicide and 3856 matched control ...
M. Mamdani +7 more
semanticscholar +1 more source